We want to learn how personality traits relate to how adolescents and young adults who are shy or whose emotions and moods change quickly make decisions. We hope this research will help us better understand decision-making and mental health during the transition from adolescence to adulthood.

Are you currently pregnant and at high risk for early delivery or high blood pressure? We're studying whether a personalized prenatal care program with extra support can help reduce stress and improve outcomes for you and your baby-without extra clinic visits. Compensation included.

Do you have incurable, metastatic, or recurrent head and neck squamous cell carcinoma? If so, you may be able to participate in a study to evaluate the addition of the anti-cancer drug, Cetuximab, to standard of care treatment.

Have you been diagnosed with early-stage breast cancer or ductal carcinoma in situ (DCIS) and have undergone breast conserving surgery (lumpectomy). If so this may be the research for you!! You may be able to take part in a research study to evaluate the effects of the tumor bed boost when given at the same time (called a simultaneous integrated boost, SIB) with the WBI, as opposed to after the WBI.

The purpose of this study to see if the drug ruxolitinib with the drugs tacrolimus and methotrexate given before and following a peripheral blood stem cell transplant will prevent graft-versus-host disease (GVHD), a serious complication of a stem cell transplant, better than the drugs post-transplant cyclophosphamide, tacrolimus, and mycophenolate mofetil.

Do you have sickle cell trait or wonder if you might? Join our study to learn more about how having sickle cell trait could impact your health. The study uses simple lab tests, and participants receive compensation.

The purpose of this research is to evaluate the various mood symptoms linked to Perimenopausal Depression (PMD) among a diverse group of women in the menopause transition.

To determine how Athletic Trainers' perceive the effectiveness of concussion risk reduction strategies and how their experiences vary in dealing with concussion risk reduction strategies.

If you have a solid tumor that has not responded to other treatments and have no remaining therapy options, you may be eligible for the trial. Participants will receive the study drug at no cost.

The purpose of this study is to see if adding LY3537982 to standard cancer treatments works better than just using the standard treatments alone for people with advanced non-small cell lung cancer (NSCLC) who have not yet been treated.